Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Zanotti

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2009
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsPatrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, et al.
Clinical Case Reports|December 12, 2017
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosisMassimiliano Bonifacio, Roberta Zanotti, Emanuele Guardalben, et al.
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2015
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levelsRoberta Zanotti, Carla Lombardo, Giovanni Passalacqua, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2017
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be SuspectedPatrizia Bonadonna, Roberta Zanotti, Mauro Pagani, et al.
Clinical Case Reports|July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosisManlio Fazio, Calogero Vetro, Uroš Markovic, et al.
Bone|June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposalIlaria Tanasi, Lara Crosera, Francesco Taus, et al.
Leukemia Research|January 14, 2015
The impact of sensitive KIT D816V detection on recognition of indolent Systemic MastocytosisGiovanna De Matteis, Roberta Zanotti, Sabrina Colarossi, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2009
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsPatrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, et al.
Clinical Case Reports|December 12, 2017
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosisMassimiliano Bonifacio, Roberta Zanotti, Emanuele Guardalben, et al.
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2015
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levelsRoberta Zanotti, Carla Lombardo, Giovanni Passalacqua, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2017
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be SuspectedPatrizia Bonadonna, Roberta Zanotti, Mauro Pagani, et al.
Clinical Case Reports|July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosisManlio Fazio, Calogero Vetro, Uroš Markovic, et al.
Bone|June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposalIlaria Tanasi, Lara Crosera, Francesco Taus, et al.
Leukemia Research|January 14, 2015
The impact of sensitive KIT D816V detection on recognition of indolent Systemic MastocytosisGiovanna De Matteis, Roberta Zanotti, Sabrina Colarossi, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
Pageof 8